Industry Research Reports
Home > Reports > Medical Devices & Consumables > Instruments for Peptide Drug Synthesis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Instruments for Peptide Drug Synthesis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-05-06
Pages: 115 Pages
Report ld: 4724601
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Instruments for Peptide Drug Synthesis Market Size(US$)
CAGR 2025-2031
7.8%
Market Size,2031
USD 354
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 225 million
Market Forecast in 2031(Value)
US$ 354 million
CAGR
7.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Instruments for Peptide Drug Synthesis was estimated to be worth US$ 214 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Instruments for Peptide Drug Synthesis cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Peptide drug synthesis equipment refers to specialized instruments designed for the synthesis of peptide-based compounds, widely used in research, pilot-scale production, and commercial manufacturing of peptide drugs. Key equipment includes solid-phase peptide synthesizers (such as automatic peptide synthesizers), liquid-phase synthesis systems, purification systems (e.g., preparative HPLC), freeze dryers, and analytical instruments (such as mass spectrometers and amino acid analyzers). These tools support the entire workflow—from synthesis and modification to purification and structural confirmation—with high efficiency and automation. As peptide drug development advances, synthesis equipment is evolving toward high-throughput, modular, and intelligent systems to accommodate the production of complex peptides and meet stringent purity requirements.
North American market for Instruments for Peptide Drug Synthesis was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Instruments for Peptide Drug Synthesis was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Instruments for Peptide Drug Synthesis was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Instruments for Peptide Drug Synthesis include AAPPTec, Gyros Protein Technologies, CEM, Shimadzu, Biotage, Peptide Scientific, CSBio, Activotec, Hainan JBPharm, Agilent Technologies, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Instruments for Peptide Drug Synthesis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Instruments for Peptide Drug Synthesis by region & country, by Type, and by Application.
The Instruments for Peptide Drug Synthesis market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Instruments for Peptide Drug Synthesis.
MARKET SEGMENTATION
By Company
- AAPPTec
- Gyros Protein Technologies
- CEM
- Shimadzu
- Biotage
- Peptide Scientific
- CSBio
- Activotec
- Hainan JBPharm
- Agilent Technologies
- Thermo Fisher Scientific
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Peptide Synthesizer
- Purification Equipment
- Others
Segment by Application
- Pharmaceutical and Biotechnology Companies
- Synthetic Services Company
- Research Institutions
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Instruments for Peptide Drug Synthesis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Instruments for Peptide Drug Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Instruments for Peptide Drug Synthesis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Instruments for Peptide Drug Synthesis Product Introduction
1.2 Global Instruments for Peptide Drug Synthesis Market Size Forecast
1.2.1 Global Instruments for Peptide Drug Synthesis Sales Value (2020-2031)
1.2.2 Global Instruments for Peptide Drug Synthesis Sales Volume (2020-2031)
1.2.3 Global Instruments for Peptide Drug Synthesis Sales Price (2020-2031)
1.3 Instruments for Peptide Drug Synthesis Market Trends & Drivers
1.3.1 Instruments for Peptide Drug Synthesis Industry Trends
1.3.2 Instruments for Peptide Drug Synthesis Market Drivers & Opportunity
1.3.3 Instruments for Peptide Drug Synthesis Market Challenges
1.3.4 Instruments for Peptide Drug Synthesis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Instruments for Peptide Drug Synthesis Players Revenue Ranking (2024)
2.2 Global Instruments for Peptide Drug Synthesis Revenue by Company (2020-2025)
2.3 Global Instruments for Peptide Drug Synthesis Players Sales Volume Ranking (2024)
2.4 Global Instruments for Peptide Drug Synthesis Sales Volume by Company Players (2020-2025)
2.5 Global Instruments for Peptide Drug Synthesis Average Price by Company (2020-2025)
2.6 Key Manufacturers Instruments for Peptide Drug Synthesis Manufacturing Base and Headquarters
2.7 Key Manufacturers Instruments for Peptide Drug Synthesis Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Instruments for Peptide Drug Synthesis
2.9 Instruments for Peptide Drug Synthesis Market Competitive Analysis
2.9.1 Instruments for Peptide Drug Synthesis Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Instruments for Peptide Drug Synthesis Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Instruments for Peptide Drug Synthesis as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Peptide Synthesizer
3.1.2 Purification Equipment
3.1.3 Others
3.2 Global Instruments for Peptide Drug Synthesis Sales Value by Type
3.2.1 Global Instruments for Peptide Drug Synthesis Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Instruments for Peptide Drug Synthesis Sales Value, by Type (2020-2031)
3.2.3 Global Instruments for Peptide Drug Synthesis Sales Value, by Type (%) (2020-2031)
3.3 Global Instruments for Peptide Drug Synthesis Sales Volume by Type
3.3.1 Global Instruments for Peptide Drug Synthesis Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Instruments for Peptide Drug Synthesis Sales Volume, by Type (2020-2031)
3.3.3 Global Instruments for Peptide Drug Synthesis Sales Volume, by Type (%) (2020-2031)
3.4 Global Instruments for Peptide Drug Synthesis Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotechnology Companies
4.1.2 Synthetic Services Company
4.1.3 Research Institutions
4.2 Global Instruments for Peptide Drug Synthesis Sales Value by Application
4.2.1 Global Instruments for Peptide Drug Synthesis Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Instruments for Peptide Drug Synthesis Sales Value, by Application (2020-2031)
4.2.3 Global Instruments for Peptide Drug Synthesis Sales Value, by Application (%) (2020-2031)
4.3 Global Instruments for Peptide Drug Synthesis Sales Volume by Application
4.3.1 Global Instruments for Peptide Drug Synthesis Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Instruments for Peptide Drug Synthesis Sales Volume, by Application (2020-2031)
4.3.3 Global Instruments for Peptide Drug Synthesis Sales Volume, by Application (%) (2020-2031)
4.4 Global Instruments for Peptide Drug Synthesis Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Instruments for Peptide Drug Synthesis Sales Value by Region
5.1.1 Global Instruments for Peptide Drug Synthesis Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Instruments for Peptide Drug Synthesis Sales Value by Region (2020-2025)
5.1.3 Global Instruments for Peptide Drug Synthesis Sales Value by Region (2026-2031)
5.1.4 Global Instruments for Peptide Drug Synthesis Sales Value by Region (%), (2020-2031)
5.2 Global Instruments for Peptide Drug Synthesis Sales Volume by Region
5.2.1 Global Instruments for Peptide Drug Synthesis Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Instruments for Peptide Drug Synthesis Sales Volume by Region (2020-2025)
5.2.3 Global Instruments for Peptide Drug Synthesis Sales Volume by Region (2026-2031)
5.2.4 Global Instruments for Peptide Drug Synthesis Sales Volume by Region (%), (2020-2031)
5.3 Global Instruments for Peptide Drug Synthesis Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
5.4.2 North America Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
5.5.2 Europe Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
5.6.2 Asia Pacific Instruments for Peptide Drug Synthesis Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
5.7.2 South America Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
5.8.2 Middle East & Africa Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Value and Sales Volume
6.2.1 Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.2.2 Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.3.2 United States Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Instruments for Peptide Drug Synthesis Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.4.2 Europe Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Instruments for Peptide Drug Synthesis Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.5.2 China Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
6.5.3 China Instruments for Peptide Drug Synthesis Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.6.2 Japan Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Instruments for Peptide Drug Synthesis Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.7.2 South Korea Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Instruments for Peptide Drug Synthesis Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.8.2 Southeast Asia Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Instruments for Peptide Drug Synthesis Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Instruments for Peptide Drug Synthesis Sales Value, 2020-2031
6.9.2 India Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
6.9.3 India Instruments for Peptide Drug Synthesis Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 AAPPTec
7.1.1 AAPPTec Company Information
7.1.2 AAPPTec Introduction and Business Overview
7.1.3 AAPPTec Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 AAPPTec Instruments for Peptide Drug Synthesis Product Offerings
7.1.5 AAPPTec Recent Development
7.2 Gyros Protein Technologies
7.2.1 Gyros Protein Technologies Company Information
7.2.2 Gyros Protein Technologies Introduction and Business Overview
7.2.3 Gyros Protein Technologies Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Gyros Protein Technologies Instruments for Peptide Drug Synthesis Product Offerings
7.2.5 Gyros Protein Technologies Recent Development
7.3 CEM
7.3.1 CEM Company Information
7.3.2 CEM Introduction and Business Overview
7.3.3 CEM Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CEM Instruments for Peptide Drug Synthesis Product Offerings
7.3.5 CEM Recent Development
7.4 Shimadzu
7.4.1 Shimadzu Company Information
7.4.2 Shimadzu Introduction and Business Overview
7.4.3 Shimadzu Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Shimadzu Instruments for Peptide Drug Synthesis Product Offerings
7.4.5 Shimadzu Recent Development
7.5 Biotage
7.5.1 Biotage Company Information
7.5.2 Biotage Introduction and Business Overview
7.5.3 Biotage Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Biotage Instruments for Peptide Drug Synthesis Product Offerings
7.5.5 Biotage Recent Development
7.6 Peptide Scientific
7.6.1 Peptide Scientific Company Information
7.6.2 Peptide Scientific Introduction and Business Overview
7.6.3 Peptide Scientific Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Peptide Scientific Instruments for Peptide Drug Synthesis Product Offerings
7.6.5 Peptide Scientific Recent Development
7.7 CSBio
7.7.1 CSBio Company Information
7.7.2 CSBio Introduction and Business Overview
7.7.3 CSBio Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 CSBio Instruments for Peptide Drug Synthesis Product Offerings
7.7.5 CSBio Recent Development
7.8 Activotec
7.8.1 Activotec Company Information
7.8.2 Activotec Introduction and Business Overview
7.8.3 Activotec Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Activotec Instruments for Peptide Drug Synthesis Product Offerings
7.8.5 Activotec Recent Development
7.9 Hainan JBPharm
7.9.1 Hainan JBPharm Company Information
7.9.2 Hainan JBPharm Introduction and Business Overview
7.9.3 Hainan JBPharm Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Hainan JBPharm Instruments for Peptide Drug Synthesis Product Offerings
7.9.5 Hainan JBPharm Recent Development
7.10 Agilent Technologies
7.10.1 Agilent Technologies Company Information
7.10.2 Agilent Technologies Introduction and Business Overview
7.10.3 Agilent Technologies Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Agilent Technologies Instruments for Peptide Drug Synthesis Product Offerings
7.10.5 Agilent Technologies Recent Development
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Company Information
7.11.2 Thermo Fisher Scientific Introduction and Business Overview
7.11.3 Thermo Fisher Scientific Instruments for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Thermo Fisher Scientific Instruments for Peptide Drug Synthesis Product Offerings
7.11.5 Thermo Fisher Scientific Recent Development
8 Industry Chain Analysis
8.1 Instruments for Peptide Drug Synthesis Industrial Chain
8.2 Instruments for Peptide Drug Synthesis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Instruments for Peptide Drug Synthesis Sales Model
8.5.2 Sales Channel
8.5.3 Instruments for Peptide Drug Synthesis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Instruments for Peptide Drug Synthesis Market Trends
Table 2. Instruments for Peptide Drug Synthesis Market Drivers & Opportunity
Table 3. Instruments for Peptide Drug Synthesis Market Challenges
Table 4. Instruments for Peptide Drug Synthesis Market Restraints
Table 5. Global Instruments for Peptide Drug Synthesis Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Instruments for Peptide Drug Synthesis Revenue Market Share by Company (2020-2025)
Table 7. Global Instruments for Peptide Drug Synthesis Sales Volume by Company (2020-2025) & (Units)
Table 8. Global Instruments for Peptide Drug Synthesis Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Instruments for Peptide Drug Synthesis Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Instruments for Peptide Drug Synthesis Manufacturing Base and Headquarters
Table 11. Key Manufacturers Instruments for Peptide Drug Synthesis Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Instruments for Peptide Drug Synthesis
Table 13. Global Instruments for Peptide Drug Synthesis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Instruments for Peptide Drug Synthesis as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Instruments for Peptide Drug Synthesis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Instruments for Peptide Drug Synthesis Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Instruments for Peptide Drug Synthesis Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Instruments for Peptide Drug Synthesis Sales Market Share in Value by Type (2020-2025)
Table 20. Global Instruments for Peptide Drug Synthesis Sales Market Share in Value by Type (2026-2031)
Table 21. Global Instruments for Peptide Drug Synthesis Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
Table 22. Global Instruments for Peptide Drug Synthesis Sales Volume by Type (2020-2025) & (Units)
Table 23. Global Instruments for Peptide Drug Synthesis Sales Volume by Type (2026-2031) & (Units)
Table 24. Global Instruments for Peptide Drug Synthesis Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Instruments for Peptide Drug Synthesis Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Instruments for Peptide Drug Synthesis Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Instruments for Peptide Drug Synthesis Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Instruments for Peptide Drug Synthesis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Instruments for Peptide Drug Synthesis Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Instruments for Peptide Drug Synthesis Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Instruments for Peptide Drug Synthesis Sales Market Share in Value by Application (2020-2025)
Table 32. Global Instruments for Peptide Drug Synthesis Sales Market Share in Value by Application (2026-2031)
Table 33. Global Instruments for Peptide Drug Synthesis Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
Table 34. Global Instruments for Peptide Drug Synthesis Sales Volume by Application (2020-2025) & (Units)
Table 35. Global Instruments for Peptide Drug Synthesis Sales Volume by Application (2026-2031) & (Units)
Table 36. Global Instruments for Peptide Drug Synthesis Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Instruments for Peptide Drug Synthesis Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Instruments for Peptide Drug Synthesis Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Instruments for Peptide Drug Synthesis Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Instruments for Peptide Drug Synthesis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Instruments for Peptide Drug Synthesis Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Instruments for Peptide Drug Synthesis Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Instruments for Peptide Drug Synthesis Sales Value by Region (2020-2025) & (%)
Table 44. Global Instruments for Peptide Drug Synthesis Sales Value by Region (2026-2031) & (%)
Table 45. Global Instruments for Peptide Drug Synthesis Sales Volume by Region (Units): 2020 VS 2024 VS 2031
Table 46. Global Instruments for Peptide Drug Synthesis Sales Volume by Region (2020-2025) & (Units)
Table 47. Global Instruments for Peptide Drug Synthesis Sales Volume by Region (2026-2031) & (Units)
Table 48. Global Instruments for Peptide Drug Synthesis Sales Volume by Region (2020-2025) & (%)
Table 49. Global Instruments for Peptide Drug Synthesis Sales Volume by Region (2026-2031) & (%)
Table 50. Global Instruments for Peptide Drug Synthesis Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Instruments for Peptide Drug Synthesis Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Volume, (2020-2025) & (Units)
Table 56. Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Volume, (2026-2031) & (Units)
Table 57. AAPPTec Company Information
Table 58. AAPPTec Introduction and Business Overview
Table 59. AAPPTec Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. AAPPTec Instruments for Peptide Drug Synthesis Product Offerings
Table 61. AAPPTec Recent Development
Table 62. Gyros Protein Technologies Company Information
Table 63. Gyros Protein Technologies Introduction and Business Overview
Table 64. Gyros Protein Technologies Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Gyros Protein Technologies Instruments for Peptide Drug Synthesis Product Offerings
Table 66. Gyros Protein Technologies Recent Development
Table 67. CEM Company Information
Table 68. CEM Introduction and Business Overview
Table 69. CEM Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. CEM Instruments for Peptide Drug Synthesis Product Offerings
Table 71. CEM Recent Development
Table 72. Shimadzu Company Information
Table 73. Shimadzu Introduction and Business Overview
Table 74. Shimadzu Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Shimadzu Instruments for Peptide Drug Synthesis Product Offerings
Table 76. Shimadzu Recent Development
Table 77. Biotage Company Information
Table 78. Biotage Introduction and Business Overview
Table 79. Biotage Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Biotage Instruments for Peptide Drug Synthesis Product Offerings
Table 81. Biotage Recent Development
Table 82. Peptide Scientific Company Information
Table 83. Peptide Scientific Introduction and Business Overview
Table 84. Peptide Scientific Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Peptide Scientific Instruments for Peptide Drug Synthesis Product Offerings
Table 86. Peptide Scientific Recent Development
Table 87. CSBio Company Information
Table 88. CSBio Introduction and Business Overview
Table 89. CSBio Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. CSBio Instruments for Peptide Drug Synthesis Product Offerings
Table 91. CSBio Recent Development
Table 92. Activotec Company Information
Table 93. Activotec Introduction and Business Overview
Table 94. Activotec Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Activotec Instruments for Peptide Drug Synthesis Product Offerings
Table 96. Activotec Recent Development
Table 97. Hainan JBPharm Company Information
Table 98. Hainan JBPharm Introduction and Business Overview
Table 99. Hainan JBPharm Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Hainan JBPharm Instruments for Peptide Drug Synthesis Product Offerings
Table 101. Hainan JBPharm Recent Development
Table 102. Agilent Technologies Company Information
Table 103. Agilent Technologies Introduction and Business Overview
Table 104. Agilent Technologies Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Agilent Technologies Instruments for Peptide Drug Synthesis Product Offerings
Table 106. Agilent Technologies Recent Development
Table 107. Thermo Fisher Scientific Company Information
Table 108. Thermo Fisher Scientific Introduction and Business Overview
Table 109. Thermo Fisher Scientific Instruments for Peptide Drug Synthesis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Thermo Fisher Scientific Instruments for Peptide Drug Synthesis Product Offerings
Table 111. Thermo Fisher Scientific Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Instruments for Peptide Drug Synthesis Downstream Customers
Table 115. Instruments for Peptide Drug Synthesis Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Instruments for Peptide Drug Synthesis Product Picture
Figure 2. Global Instruments for Peptide Drug Synthesis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Instruments for Peptide Drug Synthesis Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Instruments for Peptide Drug Synthesis Sales Volume (2020-2031) & (Units)
Figure 5. Global Instruments for Peptide Drug Synthesis Sales Price (2020-2031) & (US$/Unit)
Figure 6. Instruments for Peptide Drug Synthesis Report Years Considered
Figure 7. Global Instruments for Peptide Drug Synthesis Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Instruments for Peptide Drug Synthesis Players Sales Volume Ranking (2024) & (Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Instruments for Peptide Drug Synthesis Revenue in 2024
Figure 10. Instruments for Peptide Drug Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Peptide Synthesizer Picture
Figure 12. Purification Equipment Picture
Figure 13. Others Picture
Figure 14. Global Instruments for Peptide Drug Synthesis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Instruments for Peptide Drug Synthesis Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Instruments for Peptide Drug Synthesis Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
Figure 17. Global Instruments for Peptide Drug Synthesis Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Instruments for Peptide Drug Synthesis Price by Type (2020-2031) & (US$/Unit)
Figure 19. Product Picture of Pharmaceutical and Biotechnology Companies
Figure 20. Product Picture of Synthetic Services Company
Figure 21. Product Picture of Research Institutions
Figure 22. Global Instruments for Peptide Drug Synthesis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Instruments for Peptide Drug Synthesis Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Instruments for Peptide Drug Synthesis Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
Figure 25. Global Instruments for Peptide Drug Synthesis Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Instruments for Peptide Drug Synthesis Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America Instruments for Peptide Drug Synthesis Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Instruments for Peptide Drug Synthesis Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Instruments for Peptide Drug Synthesis Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Instruments for Peptide Drug Synthesis Sales Volume (%), (2020-2031)
Figure 39. United States Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Instruments for Peptide Drug Synthesis Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Instruments for Peptide Drug Synthesis Sales Value by Application (%), 2024 VS 2031
Figure 45. China Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
Figure 47. China Instruments for Peptide Drug Synthesis Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Instruments for Peptide Drug Synthesis Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Instruments for Peptide Drug Synthesis Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Instruments for Peptide Drug Synthesis Sales Value by Application (%), 2024 VS 2031
Figure 57. India Instruments for Peptide Drug Synthesis Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Instruments for Peptide Drug Synthesis Sales Value by Type (%), 2024 VS 2031
Figure 59. India Instruments for Peptide Drug Synthesis Sales Value by Application (%), 2024 VS 2031
Figure 60. Instruments for Peptide Drug Synthesis Industrial Chain
Figure 61. Instruments for Peptide Drug Synthesis Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Instruments for Peptide Drug Synthesis market size from 2025 to 2031?
The annual compound growth rate of the global Instruments for Peptide Drug Synthesis market is 7.8% 2025 to 2031.
Which companies rank high in the global Instruments for Peptide Drug Synthesis market?
What was the global market size of Instruments for Peptide Drug Synthesis in 2025?
Which region is expected to have the highest market share?
What was the global market size of Instruments for Peptide Drug Synthesis in 2031?
Related Reports
Global Instruments for Peptide Drug Synthesis Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Instruments for Peptide Drug Synthesis market is projected to grow from US$ 225 million in 2025 to US$ 379 million by 2032, at a CAGR of 7.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 162
USD 4900.00
(Single User License)
Global Instruments for Peptide Drug Synthesis Market Research Report 2026
The global Instruments for Peptide Drug Synthesis market was valued at US$ 225 million in 2025 and is anticipated to reach US$ 379 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 118
USD 2900.00
(Single User License)
Global Instruments for Peptide Drug Synthesis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Instruments for Peptide Drug Synthesis market size was US$ 225 million in 2025 and is forecast to reach a readjusted size of US$ 379 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 94
USD 4250.00
(Single User License)
Instruments for Peptide Drug Synthesis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Instruments for Peptide Drug Synthesis was estimated to be worth US$ 225 million in 2025 and is projected to reach US$ 379 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 121
USD 3950.00
(Single User License)
Global Instruments for Peptide Drug Synthesis Market Research Report 2025
The global market for Instruments for Peptide Drug Synthesis was valued at US$ 214 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-05-06
Pages: 93
USD 2900.00
(Single User License)
Global Instruments for Peptide Drug Synthesis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Instruments for Peptide Drug Synthesis market size was US$ 214 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-05-06
Pages: 97
USD 4250.00
(Single User License)
Global Instruments for Peptide Drug Synthesis Market Insights, Forecast to 2031
The global Instruments for Peptide Drug Synthesis market is projected to grow from US$ 225 million in 2025 to US$ 354 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Published Date: 2025-05-06
Pages: 164
USD 4900.00
(Single User License)
Global Instruments for Peptide Drug Synthesis Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Instruments for Peptide Drug Synthesis market is projected to grow from US$ 225 million in 2025 to US$ 379 million by 2032, at a CAGR of 7.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 162
USD 4900.00 (Single User License)Global Instruments for Peptide Drug Synthesis Market Research Report 2026
The global Instruments for Peptide Drug Synthesis market was valued at US$ 225 million in 2025 and is anticipated to reach US$ 379 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-03-11
Pages: 118
USD 2900.00 (Single User License)Global Instruments for Peptide Drug Synthesis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Instruments for Peptide Drug Synthesis market size was US$ 225 million in 2025 and is forecast to reach a readjusted size of US$ 379 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 94
USD 4250.00 (Single User License)Instruments for Peptide Drug Synthesis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Instruments for Peptide Drug Synthesis was estimated to be worth US$ 225 million in 2025 and is projected to reach US$ 379 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-03-09
Pages: 121
USD 3950.00 (Single User License)Global Instruments for Peptide Drug Synthesis Market Research Report 2025
The global market for Instruments for Peptide Drug Synthesis was valued at US$ 214 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-05-06
Pages: 93
USD 2900.00 (Single User License)Global Instruments for Peptide Drug Synthesis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Instruments for Peptide Drug Synthesis market size was US$ 214 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-05-06
Pages: 97
USD 4250.00 (Single User License)Global Instruments for Peptide Drug Synthesis Market Insights, Forecast to 2031
The global Instruments for Peptide Drug Synthesis market is projected to grow from US$ 225 million in 2025 to US$ 354 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Published: 2025-05-06
Pages: 164
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now